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Experiments were conducted to evaluate the effects of amphetamine (0.4 mg/kg of body weight/day) on 
the development of oral candidiasis in Sprague-Dawley rats. Animals were submitted to surgical 
hyposalivation in order to facilitate the establishment  and persistence  of Candida albicans infection.  
Treatment with drugs (placebo or amphetamine) was initiated 7 days before C. albicans inoculation and 
lasted until the end of the experiments, day 15 postinoculation. Establishment  of C. albicans infection was 
evaluated by swabbing the inoculated oral cavity with a sterile cotton applicator on days 2 and 15 after 
inoculation, followed by plating on YEPD (yeast extract-peptone-dextrose) agar. Tissue injury was 
determined by the quantification of the number and type (normal or abnormal) of papillae on the dorsal 
tongue per microscopic field. A semiquan- titative scale was devised to assess the degree of colonization of 
the epithelium by fungal hyphae. Our results show that  amphetamine  exacerbates C. albicans infection  of 
the tongues  of rats.  Significant  increases  in Candida counts, the percentage of the tongue’s surface 
covered with clinical lesions, the percentage of abnormal papillae, and the colonization of the epithelium by 
fungal hyphae were found in amphetamine-treated rats compared to those found in the rats injected with a 
placebo. The last two parameters increased in rats treated with the placebo compared to the parameters of 
the untreated control rats. 
Candida albicans is a major cause of oral and esophageal infections in immunocompromised 
patients (21). This opportunistic human pathogen preferentially causes invasive and disseminated 
infections in patients with defective phagocytic defenses and serious mucocutaneous infection in 
patients with deficiencies  in T-cell function.  Phagocytes appear to protect the host from fungal 
colonization even in the absence of adaptive immune mechanisms, while as-yet-undefined T-cell-de- 
pendent factors  seem necessary for the control  of C. albicans on body surfaces (21). 
In our previous research we had observed adverse effects of amphetamine on the immune systems 
of rodents that may lead to more severe  C. albicans infections.  Both defective T-cell- mediated 
immunity and qualitative or quantitative defects of phagocytes have been found in mice repeatedly 
injected with amphetamine (0.4 mg/kg of body weight/day). They showed a reduction in  thymus  and  
spleen  cellularities,  the  peripheral T-lymphocyte  population, the blastogenic  response  of T- and B-
lymphocyte mitogenic functions  (11, 25), the  natural  killer (NK)  cell  activity,  and  the  capacity  of  
T  cells  to  generate cytotoxic T lymphocytes  in mixed lymphocyte  cultures  and in vivo (23). A 
decrease in in vitro and in vivo phagocytoses (12), measured by the zymosan particle uptake method 
and the carbon clearance test, respectively, and a delayed-type hyper- sensitivity response in mice (13) 
were also observed. These adverse effects of amphetamine appeared after 4 days of ad- ministration 
and lasted  until the end of the experiments  (day 20), with a maximum intensity at 8 to 12 days of 
administration. Nevertheless, there  is little  data  on  the  effects  of this  compound  on  the  
development of C. albicans infection. This is important since drug addiction is commonly associated 
 with candidiasis, especially in human immunodeficiency virus patients, and  since the  potential 
immunosuppressive properties of drugs like amphetamine are not always taken into account in the 
pathogenicity  of C. albicans. To further elucidate this relationship, we studied the effects of repeated 
injections of amphetamine on the development of oral candidiasis  in rats. 
MATERIALS AND METHODS 
Animals.  Two-month-old  male  pathogen-free  rats  of  the  Sprague-Dawley strain  (Interfauna Ibérica, S.A., 
Barcelona,  Spain)  weighing 180 to 200 g were used.  They  were  housed  individually  in filter-top  cages  and  
screened  for  the presence  of C. albicans by plating oral swabs on YEPD  (yeast extract-peptone- dextrose; Sigma 
Chemical Co., St. Louis, Mo.) agar (21). The cages were kept in a temperature-controlled (22 to  24°C) and  
humidity-controlled animal  room, with an alternating light-dark  cycle (lights on at 0600 and lights off at 1800) 
and with food (diet  A.03; Panlab,  Barcelona,  Spain) and sterile  water ad libitum. 
Procedure. After verifying that the rats were free of C. albicans, we randomly divided them  into three  
experimental groups of four animals each according  to the treatment they were to be submitted  to: either no 
treatment (i.e., no placebo or  amphetamine) (control),   placebo,  or  amphetamine. Treatment with drugs started  7 
days before  C. albicans inoculation  and  lasted  until  the  end  of the experiments, day 15 postinoculation. 
Surgical hyposalivation. As in humans, xerostomia in rats facilitates the establishment and persistence of C. 
albicans infection  in the mouth;  therefore, it constitutes  a suitable animal model for the study of oral candidiasis 
(17). Si- aloadenectomy in rats causes intense  xerostomia,  but the minor salivary glands, the main producers of 
mucin, an important barrier  for mucosal permeability  and a major source of immunoglobulin A, were preserved.  
In our experiment,  xerostomia was surgically provoked  in all rats 1 month  before  treatment with drugs was 
initiated.  The  rats  were  anesthetized with  44 mg  of  ketamine   (Ketolar; Parke-Davis,  Barcelona,  Spain) per 
kg of body weight and 1 mg of diazepam (Valium;  Roche,  Madrid,  Spain)  per kg (31). The parotid  salivary 
ducts of the animals were ligated, and the submandibular and sublingual salivary glands were surgically removed  
according  to procedures previously described  (6, 20, 21). 
Source and culture of C. albicans. The C. albicans organisms used to inoculate the rats were obtained from a 
patient with erythematous oral candidiasis.  The Candida strain was grown on YEPD agar plates at room 
temperature (27). The isolated organisms were identified as C. albicans by a germ tube test and chlamydospore 
production as described by Schaar et al. (28). 
Inoculation of C. albicans. The C. albicans isolates were prepared for inoculation by suspending colonies in 
sterile buffered saline, washing and centrifuging them twice in the saline, and then resuspending them in the saline. 
The concentration of organisms  was adjusted  to 3 X 108/ml (1) by hemocytometer count. The tongues  of the 
animals were swabbed on two successive days with a cotton- tipped  applicator (21) saturated with 0.1 ml of fresh 
inoculum. 
Quantification of C. albicans cells. Establishment of C. albicans infection  was evaluated  by swabbing the 
inoculated  oral cavity with a sterile cotton  applicator, followed by plating on YEPD  agar (17). Samples were 
collected 2 days after inoculation  and at the end of the experiment.  The cotton  applicator was immediately 
immersed  in 0.99 ml of sterile isotonic saline to obtain a dilution of 10-2, and it was agitated  for 2 min. This 
dilution was considered to be 10-2. Dilutions up to 10-5  (0.1 ml) were cultured  in duplicate  in Sabouraud’s  
dextrose  agar at 37°C for 48 h. Candida colonies were counted in plates exhibiting between 30 and 300  colonies.  
Plates  with  fewer  than  30  colonies  in  the  10-2   dilution  were considered to have 101  cells (17).  
Clinical lesions. At the end of the experiment,  the animals were killed by asphyxiation in a CO2 atmosphere 
and were then decapitated. The dorsal tongue was photographed in situ at a magnification  of X10 (1). Clinical 
lesions  were measured with a digital imaging system (Técnicas Médicas MAB, Barcelona, Spain) and were 
expressed  as the percentage of the surface  area  of the tongue (percent area)  that  was covered  with the lesions. 
Tissue handling. The  tongues  from  the  rats  were hemisected in the  sagittal plane, with half of the lesion 
immersed in 10% buffered formalin for routine processing and the other  half placed in 2.5% glutaraldehyde with 
0.1 M Sorensen’s phosphate buffer at 4°C (1). 
Light microscopy. Both  hematoxylin  and eosin stain and periodic  acid-Schiff stain were used. C. albicans 
infection was assessed by evidence of lesions and by hyphal colonization  on the dorsal  tongue  (1, 24) with a 
digital imaging system. Tissue  injury  was determined by the  quantification of  the  number  and  type (normal,  
atrophic,  and hypertrophic) of papillae  per microscopic  field (magnification, X46). A semiquantitative scale was 
devised to assess the degree of colonization of the  epithelium  by fungal  hyphae.  In this scale, the  absence  of 
colonization  was given a score of 0, while maximal colonization,  where in excess of 50 hyphae could be seen in 
each high-power field (magnification,  X400), was assigned a score of 4 (24). The scores given were 1 for 1 to 5 
hyphae, 2 for 6 to 15 hyphae, and 3 for 16 to 50 hyphae. The specimens were examined by one of us, who was 
blinded as to the source. 
Scanning  electron microscopy. Following  fixation  for  24 h,  the  tissue  was rinsed three times in buffer 
and postfixed in 1% phosphate-buffered osmium tetroxide  (pH  7.4) for 1 h. After  two buffer  rinses,  the  
 specimens  were  dehydrated  in ascending  concentrations of ethanol,  followed by critical point  dehydration  in a 
Denton DCP-1 critical point drying apparatus with liquid CO2. The tissue samples were affixed on aluminum stubs 
with silver conductive  paint  and were sputter-coated with gold-palladium by using a Hummer VI sputter-coating 
apparatus (Anatech Electronics). Specimens were viewed with a Zeiss 910 electron microscope  (Zeiss, 
Oberkochen, Germany)  operated at 20 kV (2). 
Treatment with drugs. Racemic  amphetamine sulfate  (Sigma Chemical  Co.) was subcutaneously injected  
at a dose of 0.4 mg/kg in a volume of 1 ml of 0.9% saline solution per kg. The basis for employing this low dose of 
amphetamine is based on previous dose-response assays that proved to affect the immune system (12, 13, 23). Rats 
in the placebo group were subcutaneously injected with 1 ml of 
0.9% saline solution  per kg. Drugs were administered daily at 0930. 
Statistical analysis. Statistical  analysis of the quantitation of C. albicans cells in oral tissue was performed by 
using the one-way analysis of variance, followed by Bonferroni’s t test. Percent  areas of clinical lesions were 
analyzed by Student’s t test (17). The Wilcoxon signed-rank  sum test for paired  comparisons and the Kruskal-
Wallis test for multiple comparisons were used to determine the degree of colonization  of the epithelium  by 
fungal hyphae  (24). Differences  were considered  significant at a P value of <0.05. 
RESULTS 
C. albicans counts  2  and  15  days  after  inoculation   were greater  in amphetamine-treated rats 
than they were in control and placebo-treated rats (Table 1). The mean percent  areas of clinical  
legions  :±  standard deviations  in  the dorsal tongue were also greater  in amphetamine-treated rats 
(68.308 :± 5.8) than they were in control (4.160 :± 0.4) and placebo-treated (4.424 :± 0.8) rats. A 
decrease in the total number of papillae and an increase  in the percentage of abnormal (atrophic and 
hypertrophic) papillae (Fig. 1) were observed  in rats injected with amphetamine compared with the 
total numbers  and percentages observed in the control and placebo-treated rats (differences, P < 0.01). 
Significant differences (P < 0.05) between untreated controls and  placebo-injected rats  in the  latter  
parameter were observed. 
TABLE 1. C. albicans counts from the tongues of rats 
Day postinoculation 
Mean Candida count (104 CFU/,l) ± SD in rats receiving 
No treatment (control) Placebo Amphetamine 
    
2 60.75 ± 2.04 60.39 ± 2.75 65.11 ± 3.16*† 
15 4.53 ± 1.04 4.72 ± 1.75 6.33 ± 00.8*† 
    
a Establishment of C. albicans infection  was evaluated  by swabbing the inoculated  oral 
cavity with a sterile cotton  applicator,  followed by plating on YEPD agar. *, differences  
between control and amphetamine-treated rats were considered  significant  at  a  P value  of 
< 0.05; †, differences  between  placebo-  and amphetamine-treated rats were considered 
significant at a P value of <0.05. 
On the semiquantitative scale of colonization  of the epithelium by fungal hyphae  (Table  2), both  
placebo-  and amphetamine-treated rats scored higher than  untreated controls  (differences,  P < 0.05). 
Nevertheless, the  scores  were  higher  in amphetamine-injected rats than  they were in placebo-
injected rats (differences, P < 0.01). 
Clinically evident lesions and inflammatory changes of the underlying connective tissue were 
observed 15 days after C. albicans inoculation.  The latter were found in all experimental groups, but 
they were most evident in the amphetamine- treated rats. Animals showed macroscopic focal patchy 
atrophy of the dorsal tongue papillae.  Light microscopy showed localized dense zones of hyphal 
penetration of the keratin layer in the giant conical papillae and filiform papillae of the dorsal tongue.  
Microabscesses in the keratin  and the superficial  spinous layers were observed  in association  with 
hyphal invasion. The underlying connective tissue showed a mild chronic in- flammatory cell infiltrate.  
Those papillae  which supported the candidal growth appeared shorter  and blunter  than the 
surrounding  uninfected  papillae.  
  
 
FIG.  1.  Total number of papillae and percentages of normal and abnormal (atrophic and hypertrophic) papillae 
on the tongues of rats. The results are the means :± standard deviations  of four animals.  Values were analyzed 
by Bonferroni’s  t test.  *, differences between control  and  amphetamine-treated rats  were considered 
significant at a P value of <0.01; ♦, differences  between  placebo-  and amphetamine-treated rats  were 
considered significant at a P value of <0.01; ♣, differences between  control  and placebo-  and amphetamine-
treated rats were considered significant at a P value of <0.05. 
Scanning  electron  microscopy  of the  dorsal  tongues  from rats injected  with amphetamine and 
infected  with C. albicans showed a higher  loss of papillae  in the  giant conical and filiform  areas  of 
the  specimens  than  the  control  and  placebo- treated rats showed, together  with an increase in the 
size of the flat central portion of the lesion in comparison  with the control and placebo-treated rats. 
TABLE 2. Degree  of colonization  of the epithelium  by fungal hyphae Colonization score for 
rats receivinga 
Rat 
Colonization score for rats receivinga: 
No treatment (control) Placebo Amphetamine 
    
1 1 2 4 
2 1 2 3 
3 2 2 3 
4 1 2 3 
    
a A semiquantitative scale was devised to assess the degree  of colonization  of the epithelium  by 
fungal hyphae.  In this scale the absence  of colonization  was given a score  of 0, while maximal  
colonization, where  in excess of 50 hyphae could be seen in each high-powered  field 
(magnification,  X400), was assigned a score of 4. The other scores were 1 for 1 to 5 hyphae, 2 for 
6 to 15 hyphae, and 3 for 16 to 50 hyphae. 
  
 DISCUSSION 
Our results show that amphetamine exacerbates C. albicans infection  of the tongues of rats. 
Significant increases in Candida counts, the percent area of clinical lesions, the percentage of abnormal 
papillae, and the colonization of the epithelium  by fungal hyphae  were found  in amphetamine-treated 
rats com- pared  with those  found in rats injected  with the placebo.  The last two parameters increased  
in the placebo-treated rats com- pared  with the parameters of the untreated control  rats, possibly as a 
consequence of stress-induced effects of animal handling on the  immune  system (23). In previous  
investigations, we had observed  that  amphetamine did not statistically affect these  two parameters in 
noninoculated animals. 
C. albicans is an opportunistic human pathogen which preferentially causes invasive and 
disseminated infections  in patients with defective phagocytic defenses as well as serious 
mucocutaneous infection in patients  with deficiencies in T-cell function  (19). Clinical and 
experimental observations indicate that the opportunistic proclivities of this fungus vary consider- ably, 
depending on the nature of the immunological  defect of the victim. Patients with qualitative  or 
quantitative defects  of phagocytes  are  mainly prone  to the invasive form of this mycosis (8, 9, 30). In 
contrast, defective T-cell-mediated immunity has been specifically associated  with thrush and other 
forms of candidiasis limited to mucocutaneous surfaces (10, 15, 18). In this regard,  Krause  and 
Schaffner  (19) demonstrated that  cy- closporine,  a relatively selective suppressor  of T-cell-mediated 
immunity and NK cell activity, promoted the formation of thrushlike  lesions in artificial pneumatized 
cyst surfaces and impeded  the elimination  of C. albicans from such lesions, but it had no effect on 
systemic candidiasis induced by intravenous inoculation. 
These results are in agreement with previous reports on the adverse effects of amphetamine on the 
immune systems of rodents. Both defective T-cell-mediated immunity (11, 12) and qualitative or 
quantitative  defects of phagocytes (12) have been found in mice repeatedly injected with 
amphetamine. Moreover, amphetamine was found to decrease  the resistance to and  the  development 
and  passive transfer  of immunity  to Listeria monocytogenes (11) in C57BL/6 mice and to increase 
the lethality and pathogenicity  of influenza A virus (PR8/34) in CD-1 mice (22). 
The  mechanism  for  the  action  of amphetamine might  be either direct (at a target cell) or indirect 
(affecting neuroendocrine pathways). House et al. (16) found that natural and synthetic amphetamines 
exhibit direct immunomodulatory activities following in vitro exposure. Amphetamine was found to 
suppress interleukin 2 production by T lymphocytes, B-lym- phocyte proliferation, and NK cell 
function under in vitro conditions. 
The effects of amphetamine can also be secondary to a mediator involved in expressing the drug’s 
effect.  Amphetamine  has been  shown to have numerous effects on neuronal and  endocrine systems.  
Molecular products of cells  of  the nervous and immune systems provide a means of communication 
between the two systems (5). Many of the effects of amphetamine involve the drug modulation of the 
adrenergic  sys- tem and mimic stress-like states (3, 7, 14, 29). Cellular immune activity is partially 
regulated  by the adrenergic  nervous system (4). 
A second point  to be considered concerns  the  neuroendocrinological  effects of amphetamine. The 
stimulatory  effect of amphetamine on  adrenocorticotropic hormone (ACTH) and adrenocorticoids 
should  be involved (16, 25). Firstly, ACTH from the  pituitary gland, and even ir-ACTH of  
lymphocyte of immune cells. Secondly, the rise in plasma corticosterone concentrations, via ACTH  
secretion  enhancement, suppresses various  aspects  of immune  function  (26).  Previous 
investigations have shown a stimulatory effect of chronic amphetamine on ACTH  secretion  that  was 
proportional to the  decrease  in the functional activities of spleen cells and the activity of phagocytosis 
(12). Nevertheless, it was observed that adrenalectomized mice showed less but statistically significant 
immunosuppression in response to amphetamine administration. 
This led members of our group to believe that other neuropeptides and neurotransmitters (i.e., 
prolactin, endorphins, thyrotropin, and dopamine) might be involved in the immunological response to 
amphetamine. However,  the  large number  of interactions at the molecular,  cellular,  and functional  
levels be- tween the nervous  and immune  systems that  characterize the operational compositions  and 
expressions of the neuroimmune network  make the isolation  of the pathways in which amphetamine  
may be involved in the  regulation  of the  immune  responses  complex.  Therefore, many questions 
still need to be addressed in order to understand more  fully the immunosuppressive characteristics of 
amphetamine.  
 In conclusion,  our data  at present  show that  amphetamine, through  known  and  unknown  
neuroendocrine  pathways, should  injure  the  elements  of the  immunological  apparatus, which in 
turn may leave the subject vulnerable  to the action of C. albicans. 
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